AI assistant
Emami Ltd Investor Presentation 2026
61637_rns_2026-05-21_3ae960c7-e272-4daa-bcab-c7eea0675a63.pdf
Investor Presentation
Open in viewerOpens in your device viewer
emami LIMITED
21st May, 2026
The Manager – Listing
National Stock Exchange of India Ltd.
Exchange Plaza, Plot No. C/1, Block - G
Bandra Kurla Complex, Bandra (E)
Mumbai – 400 051
Scrip Code: EMAMILTD
The Manager – Listing
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai – 400 001
Scrip Code: 531162
Sub.: Press Release and Investor Presentation
Dear Sir/ Madam,
Pursuant to the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release and Investor Presentation on the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March, 2026.
The aforesaid information will also be available on the Company’s website at www.emamiltd.in.
This is for your information and record.
Thanking you,
Yours faithfully,
For Emami Limited
Ravi Varma
Company Secretary & Compliance Officer
Membership No.: F9531
(Encl: As above)
emami GROUP
EMAMI LIMITED
Regd. Office: Emami Tower, 687 Anandapur, E.M. Bypass, Kolkata 700107, West Bengal, India
P: +91 33 6613 6264 E: [email protected] W: www.emamiltd.com
CIN: L63993WB1983PLC036030
emami LIMITED
emami GROUP
Emami Reports Q4FY26 Results; Core Domestic Portfolio Remains Resilient Amid External Headwinds
- Non-summer domestic portfolio delivered healthy growth of 11%, demonstrating resilience amid a disrupted summer season
- Organised channels continued to gain salience, contributing approximately 32% to domestic business; Quick Commerce and GT Marts witnessed rapid growth
- International business revenues declined by 5% in Q4FY26 due to geopolitical disruptions in the West Asia region
- Consolidated revenues and EBITDA declined by 4% and 15%, respectively
- Strategic investments undertaken in Q1FY27 to strengthen future growth portfolio:
- ☑ Increased stake in Axiom Ayurveda (AloFrut), making it a subsidiary of the Company; Acquisition of the remaining stake to be completed by June 2026.
- ☑ Acquiring majority stake in IncNut, strengthening presence in the personalised beauty and personal care (BPC) segment through Vedix and SkinKraft.
Kolkata, Thursday, 21st May 2026:
The Board of Directors of Emami Limited met on Thursday, 21 May 2026 to consider the audited financial results of the Company for the fourth quarter and year ended FY26.
The quarter was impacted by unfavourable seasonal conditions affecting the summer portfolio, along with geopolitical disruptions in West Asia. Despite these temporary external headwinds, the Company's underlying business fundamentals remained resilient and well-positioned for long-term growth. Emami believes these challenges represent a passing phase rather than a structural concern and expects business momentum to improve progressively in the coming quarters.
On a consolidated basis, Revenue from Operations declined by 4% to ₹925 crore during Q4FY26. Excluding the summer portfolio, the domestic business delivered strong growth of 11%, led by healthy performance across key brands and categories, demonstrating the strength of the underlying business and reaffirming that the impact on overall performance was primarily due to temporary seasonal disruptions during the quarter.
The Company's omnichannel strategy continued to deliver encouraging results, with trade pipelines remaining healthy throughout the quarter. Organised channels further increased their salience to approximately 32% of the domestic business, reinforcing the strength of Emami's distribution network and market reach.
The International Business declined by 5% during the quarter, primarily on account of the West Asia conflict which impacted shipping routes through the Strait of Hormuz, disrupted supply chains and increased freight costs. The Company remains committed to its international markets and expects a gradual normalization as the geopolitical situation stabilises.
emami LIMITED
emami GROUP
Despite input cost pressures during the quarter, the Company improved its Gross Margins to 68.4%, an expansion of 250 basis points, reflecting disciplined cost management, calibrated pricing actions and operational efficiencies. EBITDA for the quarter stood at ₹187 crore, while the Company continued to invest behind its brands and growth initiatives, with advertising and promotional spends increasing by 12%. Profit after Tax for the quarter stood at ₹143 crore.
For FY26, revenues stood at ₹3780 crore. Gross Margins expanded by 130 basis points to 69.9%. EBITDA stood at ₹964 crore and PAT at ₹775 crore. During the year, the business navigated multiple external disruptions including seasonal volatility, GST 2.0 implementation and geopolitical headwinds, while continuing to strengthen its core brands and competitive positioning.
With a strong long-term vision, the Company continues to invest in its existing brands to fuel sustainable growth while simultaneously making strategic investments in emerging new-age FMCG segments. The Company remains agile and well-equipped to navigate uncontrollable external challenges that may arise from time to time, while staying firmly focused on long-term value creation.
In a significant strategic development, the Company increased its stake in Axiom Ayurveda, making it a subsidiary of the Company with effect from 1 April 2026. The acquisition marks Emami's entry into the fast-growing healthy beverage segment through Axiom's flagship brand, AloFrut, which caters to evolving consumer preferences for wellness-oriented and refreshing beverages.
Further strengthening its new-age consumer portfolio, the Company is acquiring a majority stake in IncNut, which owns digital-first brands such as Vedix and SkinKraft. The investment provides the Company a strategic foothold in the rapidly growing personalised beauty and personal care segment across India and global markets.
During FY26, the Board of Directors declared interim dividends aggregating to ₹10 per share, amounting to a total payout of ₹436.5 crore and representing 51% of adjusted profits. This reflects the Company's confidence in the resilience of the business and its continued commitment to shareholder value creation. The Company's balance sheet remains debt-free and well-positioned to support its future growth priorities.
Mr Harsha V Agarwal, Vice Chairman and Managing Director, Emami Limited said:
"Q4FY26 was impacted by temporary external headwinds, including unfavourable seasonal conditions affecting the summer portfolio and geopolitical disruptions in West Asia, which weighed on overall business performance during the quarter. Despite these challenges, the resilience of our core domestic business remained evident, with the non-summer portfolio delivering healthy 11% growth. Our international business also maintained strong momentum through most of the quarter before geopolitical developments in West Asia impacted operations in March.
While these factors affected near-term performance, we believe they represent a passing phase rather than a structural concern, and we expect business momentum to improve from next quarter itself.
We remain firmly focused on long-term growth through continued investments behind its core brands and strategic expansion into high-growth new-age FMCG segments. In the current financial year, we are strengthening our future growth portfolio through investments in Axiom Ayurveda and IncNut Digital, aligned with evolving consumer preferences and emerging market opportunities."
emami LIMITED
emami GROUP
Mr Mohan Goenka, Vice Chairman and Whole-Time Director, Emami Limited said:
"The quarter tested the resilience of our operating model, and the business responded with disciplined execution. Despite a muted demand environment, we delivered a gross margin expansion of 250 basis points through strong cost management and operational efficiencies, while increasing investments behind our brands by 12% to support future growth.
We are encouraged by the early trends in Q1FY27, particularly across the summer portfolio, supported by expanded distribution, focused media investments and stronger trade activation. We remain confident in the strength of our brands and our ability to deliver sustained profitable growth."
About Emami Ltd
Emami Ltd (NSE: EMAMILTD, BSE: 531162), founded in 1974, is one of India's leading FMCG companies engaged in the manufacturing and marketing of personal care and healthcare products. With a portfolio of over 550 products, Emami's trusted brands include Navratna, BoroPlus, Smart And Handsome, Zandu Balm, Menthho Plus, Kesh King, Dermicool, 7 Oils in One, Creme 21 and The Man Company among others.
Over the years, Emami has strengthened its portfolio through strategic acquisitions and investments. Following the acquisition of Zandu Pharmaceutical Works Ltd. in 2008, the Company acquired the iconic Ayurvedic hair and scalp care brand Kesh King in 2015. In 2019, Emami acquired Creme 21, a German skincare brand with strong legacy and consumer recall, followed by the acquisition of Dermicool, one of India's leading prickly heat and cool talc brands, in 2022. The Company has also expanded its presence in emerging FMCG segments through strategic investments in The Man Company, Brillare and Axiom Ayurveda, which are now subsidiaries.
Emami's products are available across more than 5.4 million retail outlets in India through a robust network of over 3,400 distributors. Internationally, the Company has a presence in over 70 countries across SAARC, MENAP, SEA, Africa, Eastern Europe and CIS regions.
Known for its strong consumer connect and impactful marketing, Emami has partnered with several leading celebrities and sports personalities over the years, including Amitabh Bachchan, Shah Rukh Khan, Salman Khan, Hrithik Roshan, Madhuri Dixit, Sachin Tendulkar, Sourav Ganguly, Sania Mirza and Saina Nehwal, among many others.
Emami Ltd. is the flagship company of the Emami Group. For more information, please visit www.emamiltd.in
For further information, please contact:
Mahasweta Sen
Head -Corporate Communications
Email: [email protected]
SWITCH TO SUNSCREEN THAT FEES WEIGHTLESS
emami LIMITED
Q4 & FY26 Performance Update
21st May 2026
emami GROUP
Q4FY26 Performance Overview
Strong growth ex-Summer Portfolio and International Business
Domestic Net Sales ex-Summer
+11%
(Vol. Grw.: +7%)
Summer Portfolio
-22%
Total Domestic Net Sales
-3%
(Vol. Grw.: -7%)
Int'l Business (Jan & Feb'26)
+16%
Int'l Business (Q4FY26)
-5%
Consol Revenues
-4%
Pain Management Range
+11%
Kesh King Range
+14%
Healthcare Range
+7%
The Man Co. & Brillare
+34%
BoroPlus Range
(ex Prickly heat powder)
+4%
7 Oils in One
+34%
emami GROUP
FY26 Performance Overview
Challenging year impacted by unfavorable seasonality
Domestic Net Sales ex-Summer +5%
Summer Portfolio -16%
Total Domestic Net Sales -1%
Int'l Business (VTD Feb'26) +8%
Int'l Business (FV26) +3%
Consol Revenues -1%
Pain Management Range +7%
Kesh King Range +12% (H2 Growth post relaunch)
Healthcare Range +5%
The Man Co. & Brillare +20%
BoroPlus Range (ex Prickly heat powder) +5%
7 Oils in One +13%
emami GROUP
Changing gears
Portfolio & Channel transformation for accelerated growth
New Age & Mainstream Portfolio
(Contribution to Domestic Business)
5 yr CAGR : 27%
Transforming the portfolio from niche to new-age mainstream offerings to strengthen relevance among young and GenZ consumers. Axiom and IncNut expected to further accelerate growth in FV27
Organised & New Age Channels
(Contribution to Domestic Business)
5 yr CAGR : 26%
Strategically reducing dependence on traditional GT and wholesale channels, in line with evolving tech-savvy consumer buying behaviour
D2C Brands
(Contribution to Domestic Business)
5 yr CAGR : 83%
D2C brands — Zanducare, The Man Company and Brillare now contribute ~9% of Domestic business, with IncNut to further accelerate pace in FV27
emami GROUP
Domestic Brand-wise performance Snapshot
| Brand | Q4FV26 Growth | FV26 Growth |
|---|---|---|
| Navratna & Dermicool Range | -21% | -15% |
| Pain Management Range | +11% | +7% |
| BoroPlus Range | -8% | +2% |
| Healthcare Range | +7% | +5% |
| Kesh King Range | +14% | -2% |
| Male Grooming Range | -4% | -5% |
| 7 Oils in One | +34% | +13% |
| The Man Company & Brillare | +34% | +20% |
| Domestic Business | -3% | -1% |
emami GROUP
Key Consumer Connect Initiatives
Pain Management Range
ATL campaign rolled out along with strong visibility during marquee cricketing events like the T20 World Cup followed by IPL
Partnered with 11 major marathons; set up pain relief zones to promote Fast Relief; reached 1 lakh+ runners;
Fast Relief collaborated with premium platforms (Times Now Pickleball Grand Prix, Telugu Celebrity Cricket League) to target premium audiences
Conducted sampling drives for all brands
Participated in Sabrimala Mela, Sundernagar Mela, Mahashivratri Mandi Mela, Magh Mela and Ayodhya-Varansi with brand experience zones
Pain Management Range
Digital Initiatives- Influencer Collaboration (148k likes), Comic Strip Style memes (21.5k likes) and Moment marketing
Healthcare Range
Zandu Chyavanprash campaign (Digital & Print) with Sonu Sood ("Sonu K Saath, Sehat ki Baat") reached 12 Cr+ consumers
Influencer-led campaign for Zandu Chyawanprash with 80+ influencers generated 1.6 Cr views
Integrated media push for Zandu Cough Syrup: TVC (Maharashtra), Digital (67 towns), Print (Delhi NCR)
emami GROUP
Key Consumer Connect Initiatives
Navratna & Dermicool Range
New TVC Thematic Campaign for South Market featuring Vennela Kishoore & Vidhyilekha Raman
Rolled out "Navratna Laughter Relief" improv comedy series on JioHotstar, garnering 4.1 mn views across 3 languages
Launched ₹10 Jar pack of Navratna Oil to enhance retail visibility and premium shelf display
Dermicool Her Campaign on Women's Day in select MT stores.
BoroPlus Range
Influencer-led Instagram campaign for BoroPlus Soft with 27 influencers generated 4.38 Mn views
Influencer campaign for BoroPlus Lip Balm with 15 creators generated 1.5 mn views
Male Grooming Range
Executed a digital-first media campaign with a re-edited copy with sharper focus on benefit superiority for Cream & Face Wash
Launched campaign on Meta to divert traffic to Flipkart, Blinkit & Swiggy
Amplified through high-impact cricket integrations (ICC Men's T20 WQ & India vs NZ series)
emami GROUP
Key Consumer Connect Initiatives
Kesh King Range
Consistent digital push and regional influencer activations for Kesh King Gold relaunch – More than 300 influencers engaged generating 75 mn views and unique reach of 50 mn
Active mela participation (Nauchandi & Rath) and rural van branding
Strategic Investments
Digital Campaign for The Man Company Anti Dandruff Shampoo
Digital campaigns for The Man Company NPD's
emami GROUP
International Business Performance
Business impacted by West Asia crisis
Q4FY26
Growth (INR)
-5%
Contribution to overall Sales
19%
FY26
Growth (INR)
+3%
Contribution to overall Sales
18%
SAARC & SEA
FY26 Contribution:
40%
MENA
FY26 Contribution:
41%
CIS
FY26 Contribution:
12%
emami GROUP
Q4FY26 Financial Analysis
Cost of Goods Sold
(as a % of Revenues)
-250 bps
Staff Costs
(as a % of Revenues)
+110 bps
A&P Spends
(as a % of Revenues)
+330 bps
Other Income
(₹ in cr)
Interest Paid
(₹ in cr)
emami GROUP
FY26 Financial Analysis
Cost of Goods Sold
(as a % of Revenues)
-130 bps
Lower by 5%
Staff Costs
(as a % of Revenues)
+100 bps
Lower by 7%
Admin & Other Exp
(as a % of Revenues)
+40 bps
Lower by 2%
Other Income
(₹ in cr)
A&P Costs
(as a % of Revenues)
+140 bps
Lower by 2%
Interest Paid
(₹ in cr)
emami GROUP
Q4FY26 Consolidated Financials
₹ in crore
| Particulars | Q4FY26 | % | Q4FY25 | % | Growth |
|---|---|---|---|---|---|
| Net Sales | 918.0 | 99.2% | 954.0 | 99.1% | -3.8% |
| Other Operating Income | 7.2 | 0.8% | 9.1 | 0.9% | -21.0% |
| Revenue from Operations | 925.1 | 100.0% | 963.0 | 100.0% | -3.9% |
| Materials Cost | 291.9 | 31.6% | 328.4 | 34.1% | -11.1% |
| A&P | 212.0 | 22.9% | 188.9 | 19.6% | 12.2% |
| Staff Cost | 117.0 | 12.6% | 110.6 | 11.5% | 5.7% |
| Admin and other expenses | 117.6 | 12.7% | 115.7 | 12.0% | 1.6% |
| EBIDTA | 186.7 | 20.2% | 219.4 | 22.8% | -14.9% |
| Other Income | 23.2 | 2.5% | 21.2 | 2.2% | 9.5% |
| Interest | 3.1 | 0.3% | 2.8 | 0.3% | 13.2% |
| Amortisation | 19.6 | 2.1% | 22.8 | 2.4% | -13.9% |
| Depreciation | 22.7 | 2.4% | 20.8 | 2.2% | 9.0% |
| PBT before share of Profit /Loss of associate | 164.5 | 17.8% | 194.3 | 20.2% | -15.3% |
| Share of Profit /(loss) of associate | (0.4) | 0.0% | (0.6) | -0.1% | -30.5% |
| Exceptional Items | - | 0.0% | - | 0.0% | |
| PBT | 164.1 | 17.7% | 193.7 | 20.1% | -15.3% |
| Tax | 20.9 | 2.3% | 31.5 | 3.3% | -33.7% |
| Profit After Tax | 143.2 | 15.5% | 162.2 | 16.8% | -11.7% |
| Non controlling interest | (0.0) | 0.0% | (0.0) | 0.0% | -81.3% |
| Profit for the Period | 143.2 | 15.5% | 162.2 | 16.8% | -11.7% |
emami GROUP
FY26 Consolidated Financials
₹ in crore
| Particulars | FY26 | % | FY25 | % | Growth |
|---|---|---|---|---|---|
| Net Sales | 3,745.3 | 99.1% | 3,765.1 | 98.8% | -0.5% |
| Other Operating Income | 34.2 | 0.9% | 44.1 | 1.2% | -22.4% |
| Revenue from Operations | 3,779.5 | 100.0% | 3,809.2 | 100.0% | -0.8% |
| Materials Cost | 1,138.0 | 30.1% | 1,194.2 | 31.4% | -4.7% |
| A&P | 739.2 | 19.6% | 694.0 | 18.2% | 6.5% |
| Staff Cost | 479.1 | 12.7% | 447.0 | 11.7% | 7.2% |
| Admin and other expenses | 459.5 | 12.2% | 448.8 | 11.8% | 2.4% |
| EBIDTA | 963.6 | 25.5% | 1,025.1 | 26.9% | -6.0% |
| Other Income | 85.1 | 2.3% | 68.1 | 1.8% | 25.0% |
| Interest | 11.1 | 0.3% | 9.3 | 0.2% | 19.2% |
| Amortisation | 88.5 | 2.3% | 92.6 | 2.4% | -4.4% |
| Depreciation | 88.9 | 2.4% | 85.7 | 2.2% | 3.8% |
| PBT before share of Profit /Loss of associate | 860.3 | 22.8% | 905.7 | 23.8% | -5.0% |
| Share of Profit /(loss) of associate | (4.1) | -0.1% | (11.8) | -0.3% | -65.6% |
| Exceptional Items | (10.1) | -0.3% | - | 0.0% | |
| PBT | 846.1 | 22.4% | 893.9 | 23.5% | -5.3% |
| Tax | 70.8 | 1.9% | 91.1 | 2.4% | -22.3% |
| Profit After Tax | 775.3 | 20.5% | 802.7 | 21.1% | -3.4% |
| Non controlling interest | (0.0) | 0.0% | (3.7) | -0.1% | -99.8% |
| Profit for the Period | 775.3 | 20.5% | 806.5 | 21.2% | -3.9% |
emami GROUP
Summarized Balance Sheet
| Sl. | Equity & Liabilities | As at 31.03.2026 | As at 31.03.2025 | Sl. | Assets | As at 31.03.2026 | As at 31.03.2025 |
|---|---|---|---|---|---|---|---|
| Audited | Audited | Audited | Audited | ||||
| (a) | EQUITY | Non -Current Assets | |||||
| Equity Share capital | 43.7 | 43.7 | (a) | Property, Plant and Equipment | 529.2 | 544.6 | |
| (b) | Other Equity | 2,880.3 | 2,651.1 | (b) | Capital work-in-progress | 0.8 | 13.3 |
| (c) | Total Equity attributable to owners of the Parent | 2,924.0 | 2,694.8 | (c) | Investment Properties | 40.1 | 51.1 |
| Non-Controlling Interest | -1.5 | -1.4 | (d) | Goodwill on Consolidation | 68.2 | 68.2 | |
| Total Equity | 2,922.4 | 2,693.4 | (e) | Other Intangible Assets | 206.8 | 292.2 | |
| (a) | LIABILITIES | (f) | Right of Use Assets | 42.2 | 28.3 | ||
| Non-Current Liabilities | (g) | Intangible assets under development | 0.6 | 1.7 | |||
| (a) | Financial Liabilities | (h) | Investments accounted for using equity method | 86.6 | 111.9 | ||
| (i) Lease Liabilities | 24.1 | 17.3 | (i) | Financial Assets | |||
| (ii) Other Financial Liabilities | 3.2 | 3.0 | (i) | (i) Investments | 275.9 | 139.8 | |
| (b) | Provisions | 31.4 | 19.3 | (ii) | (ii) Loans | 4.7 | 5.3 |
| (c) | Deferred Tax Liabilities (Net) | 5.9 | 8.4 | (iii) | (iii) Other Financial Assets | 11.4 | 10.2 |
| (d) | Other Non-Current Liabilities | 11.1 | 12.9 | (j) | Deferred Tax Assets (net) | 626.2 | 523.9 |
| 75.8 | 60.9 | Other Non-Current Assets | 9.0 | 9.5 | |||
| (a) | Current liabilities | Current assets | |||||
| Financial Liabilities | Inventories | 399.6 | 308.1 | ||||
| (a) | (i) Borrowings | 122.4 | 62.1 | (a) | Financial Assets | ||
| (ii) Lease Liabilities | 15.4 | 10.4 | (b) | (i) Investments | 471.9 | 424.0 | |
| (iii) Trade Payables | (ii) Trade Receivables | 343.3 | 451.3 | ||||
| Total outstanding dues of Micro & Small Enterprises | 53.0 | 56.1 | (iii) Cash & Cash Equivalents | 176.8 | 104.6 | ||
| Total outstanding dues of creditors Other than Micro & Small E | 424.1 | 379.5 | (iv) Bank Balances other than (iii) above | 233.1 | 168.3 | ||
| (iv) Other Financial Liabilities | 66.6 | 125.8 | (v) Loans | 23.2 | 4.2 | ||
| (b) Other Current Liabilities | 38.5 | 42.3 | (vi) Other Financial Assets | 72.9 | 129.5 | ||
| (c) | Provisions | 99.0 | 85.3 | (c) | Current Tax Assets (Net) | 0.7 | 0.5 |
| (d) | Current Tax Liabilities (Net) | 19.2 | 17.8 | (d) | Other Current Assets | 213.5 | 143.2 |
| 838.3 | 779.4 | 1,934.9 | 1,733.7 | ||||
| Total Equity and Liabilities | 3,836.4 | 3,533.6 | Total Assets | 3,836.4 | 3,533.6 |
Net Cash of ₹ 883 cr as on 31st March'26
15
FY26 Dividends
| 1^{st} Interim Dividend | 2^{nd} Interim Dividend | Total Dividend | |
|---|---|---|---|
| Declared on | 10^{th} Nov'25 | 4^{th} Feb'26 | |
| Dividend per share (₹) | 4.0/- | 6.0/- | 10.0/- |
| Dividend (%) | 400% | 600% | 1000% |
| Total Dividend payout (₹ crore) | 174.6 | 261.9 | 436.5 |
Payout of 51% on Adjusted PAT and 56% of Reported PAT
emami GROUP
ESG Initiatives
Consistent improvement over all major parameters
67,659 GJ vs 75,778 GJ
Electricity Consumption
10%
23,668 GJ vs 23,597 GJ
Renewable Energy (Contribution)
21%
(+100 bps over PV)
38,889 GJ vs 42,728 GJ
Fuel Consumption
9%
14,622 vs 16,342 tCO2e (MT of Co2 equivalent)
GHG Emissions (Scope 1+2)
11%
120,124 KL vs 142,181 KL
Water Consumption
16%
2238.23 MT vs 2482.67 MT
Waste Generated
9%
0.16 VS 0.32
Lost Time Injury Frequency Rate
50%
15 projects across 3 focus areas
CSR: Lives Impacted
7.96 lac
emami GROUP
Awards & Accolades
Mr. Harsha V. Agarwal, Vice Chairman & MD appointed as the Honorary Consul of Austria
Received the Golden Peacock National Quality Award 2026, by the Institute of Directors (IOD), India recognizing outstanding commitment to quality management and business excellence
Pacharia Unit conferred with the Greentech Energy Management Excellence Gold Award 2026 in the Industrial Energy Management category recognizing excellence in energy efficiency, sustainability and environmental stewardship.
Secured a Patent for a structurally modified Menthol blend – “Composition of Menthol Isomers and Related Compounds For Cooling and Fragrance in Cosmetic Products, highlighting advanced molecule-level research and innovation capabilities
Received appreciation from United States Pharmacopeia for developing the monograph on Shatavari roots, powder, and extract, reinforcing Emami’s contribution to global quality standards in herbal healthcare
emami GROUP
Thank You
